Advanced humanities studies in Chula Vista, California

Velocity Clinical Research, located at 754 Medical Center Court in Chula Vista, California, is a renowned health institution specializing in conducting a wide range of clinical trials. Founded in 1999 as eStudySite and acquired by Velocity in 2020, this facility collaborates with partner hospitals to conduct in-patient and out-patient protocols, from first-in-human trials to post-marketing support. With a focus on infectious diseases, endocrinology, hepatology, dermatology, and gastroenterology, the site has built a strong reputation for excellence in research. The bilingual research team excels in recruiting Latinx study participants, serving a diverse patient community near the USA/Mexican border. The facility, equipped with an inpatient/outpatient infusion center, complies with ICH and FDA guidelines, ensuring high-quality patient care and advancing medicine through research. Led by Medical Director Dr. Michael Waters and Site Director Cecilia Barbabosa, the dedicated team at Velocity Clinical Research in Chula Vista is committed to conducting quality research in a caring environment. Joining a clinical trial at Velocity can provide access to cutting-edge treatments and contribute to medical advancements for various health conditions.

ProSciento, Inc. is a leading clinical research organization located at 855 3rd Avenue, Chula Vista, California, United States. We specialize in improving the lives of patients with metabolic diseases such as diabetes, NASH, and obesity. Our team of science-driven experts is dedicated to advancing research and therapeutic development in these areas. At ProSciento, we offer a range of services including participant feasibility studies, direct patient engagement, and advanced methodologies to support our clients' commitment to improving human health. Our deep connections with clients and partners, along with our global operations exclusively focused on metabolic diseases, set us apart as a leader in the field.